Promoter holding
64.27%
SA
Samilabs - Due diligence report
A 360° intelligence report on Samilabs: trust score, financial health, credit view, compliance, directors, growth and distress signals - gen…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Samilabs — 360° Intelligence Report
Generated from MCA filings & public records68/100
Trust Score
Moderate
Samilabs is assessed as Moderate with a Trust Score of 68/100. Samilabs is an active public limited indian non-government company incorporated in 1991, operating in the Healthcare sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.
Report generated on 02 Oct 2026 from the latest processed filings. Sami-Sabinsa Group Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
68/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
47/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
75/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreCaution Indicated
40/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
50/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
70/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 75/100 Low Risk
- Working-capital cover adequate.
- Profitable - internal accruals available.
- Externally credit-rated (A).
Charges position: 4 open (227.76 cr) · 39 satisfied (538.29 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| State Bank Of India | 3 | 48.0 cr |
| Citi Bank N.A. | 2 | 48.0 cr |
| Others | 4 | 48.0 cr |
| Hdfc Bank Limited | 1 | 48.0 cr |
| Export Import Bank Of India | 6 | 48.0 cr |
| Dbs Bank Ltd | 2 | 48.0 cr |
Compliance Score: 47/100 Caution Indicated
- Company status is Active as per MCA.
- Last balance sheet is for Mar 2024 - filings overdue.
- Litigation present in 4 court forum(s).
- Delayed payments to MSME suppliers disclosed (12 disclosure(s)).
- 6 active GST registration(s).
Legal cases on record (4)
05
Director Intelligence
Stability score: 40/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| KEMAL PASHA BATHISHA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| KASARAGOD ULLAS KAMATH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SHAHEEN MUHAMMED MAJEED | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Nagarajan Muthukaman | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ANJU MAJEED | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| MADHU SUBRAMANIAN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 6 directors on the board.
- SHAHEEN MUHAMMED MAJEED has DIN status "Deactivated due to non-filing of DIR-3 KYC".
- 1 director exit(s) in the last 3 years.
Director & KMP remuneration (FY 2023)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2023 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
1
Group entities
1
Capital events
0 allotment(s) · 7 transfer(s)
| Group entity | Relationship | % held |
|---|---|---|
| Hanbury Fze, Uae | Subsidiary Company | 74.00% |
| M & S Realty, Llc Usa | Subsidiary Company | 74.00% |
| Sabinsa (nanjing) Biotech Limited, China | Subsidiary Company | 74.00% |
| Sabinsa Australia Pty Ltd, Australia | Subsidiary Company | 74.00% |
| Sabinsa Brazil Ltd | Subsidiary Company | 74.00% |
| Sabinsa Canada Inc., Canada | Subsidiary Company | 74.00% |
| Sabinsa Corporation, Usa | Subsidiary Company | 74.00% |
| Sabinsa Europe Gmbh, Germany | Subsidiary Company | 74.00% |
| Sabinsa Japan Corporation, Japan | Subsidiary Company | 74.00% |
| Sabinsa Korea Corporation, South Korea | Subsidiary Company | 74.00% |
Key managerial personnel: SHAHEEN MUHAMMED MAJEED (Managing Director) · ANJU MAJEED (Whole-time director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 50 · Distress 70
Growth signals & trust indicators
Asset base grew 38% - capacity expansion.
EPFO headcount growing - hiring signal.
Operating for 35+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Outside liabilities up 1.42 in a year.
Statutory filings appear overdue.
Compliance score is weak (47/100).
4 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 45.23 Lakh.
4 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence60/100
Review suggested
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment72/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 4 open charge(s) of 227.76 cr already registered.
- Compliance gaps should be priced into terms.
Investor view68/100
Mixed indicators
Growth quality and scalability through an investor lens.
- 2 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management churn warrants questions.
09
MCA Filings & Events Timeline
Latest 15 events10 Feb 2025
Charge satisfied
State Bank Of India
14 Nov 2024
Last AGM held
Annual general meeting
13 Nov 2024
Director ceased
Nagarajan Muthukaman
30 Sep 2024
Director appointed
Nagarajan Muthukaman (Director)
25 Jun 2024
Charge satisfied
Others
31 Mar 2024
Latest balance sheet
Filed with ROC
25 Mar 2024
Director appointed
SHAHEEN MUHAMMED MAJEED (Managing Director)
29 May 2023
Director ceased
RAMANA RAO CHEBOLU
02 May 2023
Director appointed
MADHU SUBRAMANIAN (Director)
01 Apr 2023
Director ceased
SYED MOHAMMED SALEEL
31 Mar 2023
Share transfer (FY 2023)
1250.00000000 shares to Anju Majeed
24 Mar 2023
Charge created
Citi Bank N.A. - 131.76 cr
30 Nov 2022
Director ceased
KEMAL PASHA BATHISHA
Director ceased
KASARAGOD ULLAS KAMATH
15 Nov 2022
Director ceased
SUNIL RAMAKANT BHUMRALKAR
10
Key Observations
Auto-generated from the data aboveRevenue declined 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Net worth is positive.
6 active director(s) / partner(s); review board churn before relying on management continuity.
6 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 1 subsidiary(ies) - assess on a consolidated basis.
Carries an external credit rating of A from Care.
EPFO-registered employer - verifiable payroll history exists.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
2 overseas direct investment(s) (ODI) on record - international footprint.
| Company | CIN | Location |
|---|---|---|
| Kokuyocamlin | L24223MH1946PLC005434 | Mumbai, Maharashtra, India |
| Gramercy Trade Industries Private Limited | U24112PN2021PTC205986 | Pune, Maharashtra, India |
| Paramesu Biotech Limited | U24232AP2011PLC076378 | Devarapalli, Andhra Pradesh, India |
| Eris Therapeutics Limited | U24230GJ2021PLC123519 | Ahmadabad City, Gujarat, India |
| Windlas | L74899UR2001PLC033407 | Dehradun, Uttarakhand, India |
| Neogenchem | L24200MH1989PLC050919 | Thane, Maharashtra, India |
| Symbiotec | U24232MP2002PLC015293 | Mhow, Madhya Pradesh, India |
| Sms Pharmaceuticals | L24239TG1987PLC008066 | Serilingampally, Telangana, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Samilabs before audits and certifications: compliance score 47/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Samilabs: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 75/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Mixed indicators. Growth score 50/100, margin trends, ownership structure and peer set for Samilabs - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Review suggested. Trust score 68/100, distress signals and MSME payment-delay disclosures - know whether Samilabs pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (4 case(s) on record), regulatory flags, charge documents trail and director networks for Samilabs - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Samilabs an active company?
Samilabs has MCA status “Active” with a compliance score of 47/100 (Caution Indicated).
Is Samilabs financially healthy?
Samilabs has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.
Should I do business with Samilabs?
Its overall Trust Score is 68/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Samilabs?
See the directors and ownership sections above for board and shareholding detail. 6 active director(s) are on record.
Does Samilabs have loans or charges against its assets?
4 open charge(s) are registered against its assets, and 39 earlier charge(s) stand satisfied.
Is Samilabs up to date with its ROC filings?
Last balance sheet is for Mar 2024 - filings overdue. Overall compliance score: 47/100 (Caution Indicated).
Is it risky to lend to Samilabs?
Its Credit Risk Score is 75/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
